BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 35170430)

  • 1. YAP1 activation by human papillomavirus E7 promotes basal cell identity in squamous epithelia.
    Hatterschide J; Castagnino P; Kim HW; Sperry SM; Montone KT; Basu D; White EA
    Elife; 2022 Feb; 11():. PubMed ID: 35170430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.
    Hatterschide J; Brantly AC; Grace M; Munger K; White EA
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation.
    White EA; Münger K; Howley PM
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.
    Hatterschide J; Bohidar AE; Grace M; Nulton TJ; Kim HW; Windle B; Morgan IM; Munger K; White EA
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7033-7042. PubMed ID: 30894485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV18 E7 inhibits LATS1 kinase and activates YAP1 by degrading PTPN14.
    Blakely WJ; Hatterschide J; White EA
    bioRxiv; 2024 Mar; ():. PubMed ID: 38496413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells.
    Bertagnin C; Messa L; Pavan M; Celegato M; Sturlese M; Mercorelli B; Moro S; Loregian A
    Cancer Lett; 2023 Sep; 571():216331. PubMed ID: 37532093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MmuPV1 E7's interaction with PTPN14 delays Epithelial differentiation and contributes to virus-induced skin disease.
    Romero-Masters JC; Grace M; Lee D; Lei J; DePamphilis M; Buehler D; Hu R; Ward-Shaw E; Blaine-Sauer S; Lavoie N; White EA; Munger K; Lambert PF
    PLoS Pathog; 2023 Apr; 19(4):e1011215. PubMed ID: 37036883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice.
    Nishio M; To Y; Maehama T; Aono Y; Otani J; Hikasa H; Kitagawa A; Mimori K; Sasaki T; Nishina H; Toyokuni S; Lydon JP; Nakao K; Wah Mak T; Kiyono T; Katabuchi H; Tashiro H; Suzuki A
    Cancer Sci; 2020 Oct; 111(10):3576-3587. PubMed ID: 32716083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7.
    Szalmás A; Tomaić V; Basukala O; Massimi P; Mittal S; Kónya J; Banks L
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for recognition of the tumor suppressor protein PTPN14 by the oncoprotein E7 of human papillomavirus.
    Yun HY; Kim MW; Lee HS; Kim W; Shin JH; Kim H; Shin HC; Park H; Oh BH; Kim WK; Bae KH; Lee SC; Lee EW; Ku B; Kim SJ
    PLoS Biol; 2019 Jul; 17(7):e3000367. PubMed ID: 31323018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Analysis of the Interaction between Human PTPN21 and the Oncoprotein E7 from Human Papillomavirus Genotype 18.
    Lee HS; Kim MW; Jin KS; Shin HC; Kim WK; Lee SC; Kim SJ; Lee EW; Ku B
    Mol Cells; 2021 Jan; 44(1):26-37. PubMed ID: 33431714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus targets the YAP1-LATS2 feedback loop to drive cervical cancer development.
    Huang C; Lv X; Chen P; Liu J; He C; Chen L; Wang H; Moness ML; Dong J; Rueda BR; Davis JS; Wang C
    Oncogene; 2022 Jul; 41(30):3761-3777. PubMed ID: 35761037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hippo component YAP localizes in the nucleus of human papilloma virus positive oropharyngeal squamous cell carcinoma.
    Alzahrani F; Clattenburg L; Muruganandan S; Bullock M; MacIsaac K; Wigerius M; Williams BA; Graham ME; Rigby MH; Trites JR; Taylor SM; Sinal CJ; Fawcett JP; Hart RD
    J Otolaryngol Head Neck Surg; 2017 Feb; 46(1):15. PubMed ID: 28222762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of E6 in Maintaining the Basal Cell Reservoir during Productive Papillomavirus Infection.
    Saunders-Wood T; Egawa N; Zheng K; Giaretta A; Griffin HM; Doorbar J
    J Virol; 2022 Mar; 96(5):e0118121. PubMed ID: 35019722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetic characterization of p53 mutated oropharyngeal squamous cell carcinoma cells transformed with human papillomavirus E6 and E7 oncogenes.
    Oh JE; Kim JO; Shin JY; Zhang XH; Won HS; Chun SH; Jung CK; Park WS; Nam SW; Eun JW; Kang JH
    Int J Oncol; 2013 Aug; 43(2):383-93. PubMed ID: 23708675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DEK promotes HPV-positive and -negative head and neck cancer cell proliferation.
    Adams AK; Hallenbeck GE; Casper KA; Patil YJ; Wilson KM; Kimple RJ; Lambert PF; Witte DP; Xiao W; Gillison ML; Wikenheiser-Brokamp KA; Wise-Draper TM; Wells SI
    Oncogene; 2015 Feb; 34(7):868-77. PubMed ID: 24608431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
    Callejas-Valera JL; Iglesias-Bartolome R; Amornphimoltham P; Palacios-Garcia J; Martin D; Califano JA; Molinolo AA; Gutkind JS
    Carcinogenesis; 2016 Oct; 37(10):1014-25. PubMed ID: 27538837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights in Hippo signalling alteration in human papillomavirus-related cancers.
    Olmedo-Nieva L; Muñoz-Bello JO; Manzo-Merino J; Lizano M
    Cell Signal; 2020 Dec; 76():109815. PubMed ID: 33148514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
    Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
    Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double demonstration of oncogenic high risk human papilloma virus DNA and HPV-E7 protein in oral cancers.
    Pannone G; Santoro A; Carinci F; Bufo P; Papagerakis SM; Rubini C; Campisi G; Giovannelli L; Contaldo M; Serpico R; Mazzotta M; Lo Muzio L
    Int J Immunopathol Pharmacol; 2011; 24(2 Suppl):95-101. PubMed ID: 21781453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.